Increased Nicotinamide Phosphoribosyltransferase in Rhabdomyosarcomas and Leiomyosarcomas Compared to Skeletal and Smooth Muscle Tissue

Overview

Journal Anticancer Res

Specialty Oncology

Date 2016 Feb 7

PMID 26851003

Citations 21

Authors

Moiz Vora

Junaid Ansari

Rabie M Shanti

Diana Veillon

James Cotelingam

Domenico Coppola

Rodney E Shackelford

Affiliations

Soon will be listed here.

Abstract

Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step in NAD synthesis and is up-regulated in several human malignancies, including breast, colon, prostate, thyroid, gastric, and several hematopoietic malignancies. In some malignancies, such as gastric, thyroid, and prostate carcinomas, higher NAMPT expression correlates with deeper tumor invasion, increased metastatic potential and chemotherapy resistance. We employed tissue microarray immunohistochemistry to examine NAMPT expression in benign skeletal and smooth muscle, leiomyomas, leiomyosarcomas (graded low-, intermediate-, and high-grade), and spindle, embryonal, pleomorphic, and alveolar rhabdomyosarcomas. We found low to intermediate NAMPT expression in benign tissue, leiomyomas, leiomyosarcomas (low- and intermediate-grades), and spindle cell rhabdomyosarcomas. In contrast, high-grade leiomyosarcomas and embryonal, alveolar, and pleomorphic rhabdomyosarcomas showed high NAMPT expression. Herein we show for the first time that NAMPT is overexpressed in certain sarcoma types and the level of NAMPT expression correlates with tumor behavior.

Citing Articles

Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models.

McKay-Corkum G, Collins V, Yeung C, Ito T, Issaq S, Holland D Clin Cancer Res. 2023; 29(21):4479-4491.

PMID: 37616468 PMC: 10841338. DOI: 10.1158/1078-0432.CCR-23-0200.

Extracellular Nicotinamide Phosphoribosyltransferase as a Surrogate Marker of Prominent Malignant Potential in Colonic Polyps: A 2-Year Prospective Study.

Chen T, Hsu H, You J, Lai C, Tsou Y, Hsu C Cancers (Basel). 2023; 15(6).

PMID: 36980589 PMC: 10046025. DOI: 10.3390/cancers15061702.

Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.

Xu N, Yu Y, Duan C, Wei J, Sun W, Jiang C Clin Proteomics. 2023; 20(1):10.

PMID: 36918772 PMC: 10012572. DOI: 10.1186/s12014-023-09401-4.

NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets.

Indini A, Fiorilla I, Ponzone L, Calautti E, Audrito V Int J Mol Sci. 2022; 23(17).

PMID: 36077374 PMC: 9456568. DOI: 10.3390/ijms23179985.

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).

He M, Cao C, Ni Z, Liu Y, Song P, Hao S Signal Transduct Target Ther. 2022; 7(1):181.

PMID: 35680848 PMC: 9178337. DOI: 10.1038/s41392-022-00999-9.

References

Lack E, Steinberg S, White D, Kinsella T, Glatstein E, Chang A . Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol. 1989; 41(4):263-73. DOI: 10.1002/jso.2930410414. View

Mosquera J, Sboner A, Zhang L, Kitabayashi N, Chen C, Sung Y . Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer. 2013; 52(6):538-50. PMC: 3734530. DOI: 10.1002/gcc.22050. View

Agaram N, Chen C, Zhang L, LaQuaglia M, Wexler L, Antonescu C . Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. Genes Chromosomes Cancer. 2014; 53(9):779-87. PMC: 4108340. DOI: 10.1002/gcc.22187. View

Bae S, Kim S, Kim J, Kim J, Koo T, Jang H . Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett. 2006; 580(17):4105-13. DOI: 10.1016/j.febslet.2006.06.052. View

Bi T, Che X, Liao X, Zhang D, Long H, Li H . Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil. Oncol Rep. 2011; 26(5):1251-7. DOI: 10.3892/or.2011.1378. View

HAJDU S, Shiu M, Brennan M . The role of the pathologist in the management of soft tissue sarcomas. World J Surg. 1988; 12(3):326-31. DOI: 10.1007/BF01655665. View

Gladdy R, Qin L, Moraco N, Agaram N, Brennan M, Singer S . Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol. 2013; 20(6):1851-7. PMC: 3657306. DOI: 10.1245/s10434-013-2876-y. View

Li Y, Zhang Y, Dorweiler B, Cui D, Wang T, Woo C . Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem. 2008; 283(50):34833-43. PMC: 2596403. DOI: 10.1074/jbc.M805866200. View

RUYMANN F, Grovas A . Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas. Cancer Invest. 2001; 18(3):223-41. DOI: 10.3109/07357900009031827. View

10.

Fasih N, Prasad Shanbhogue A, MacDonald D, Fraser-Hill M, Papadatos D, Kielar A . Leiomyomas beyond the uterus: unusual locations, rare manifestations. Radiographics. 2008; 28(7):1931-48. DOI: 10.1148/rg.287085095. View

11.

Chen C, Loy A, Cen L, Chan C, Hsieh F, Cheng G . Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer. 2007; 7:111. PMC: 1964761. DOI: 10.1186/1471-2407-7-111. View

12.

Shackelford R, Mayhall K, Maxwell N, Kandil E, Coppola D . Nicotinamide phosphoribosyltransferase in malignancy: a review. Genes Cancer. 2014; 4(11-12):447-56. PMC: 3877665. DOI: 10.1177/1947601913507576. View

13.

Shintani K, Matsumine A, Kusuzaki K, Matsubara T, Satonaka H, Wakabayashi T . Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas. Virchows Arch. 2006; 449(6):673-81. DOI: 10.1007/s00428-006-0304-4. View

14.

Hasmann M, Schemainda I . FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003; 63(21):7436-42. View

15.

Guillou L, Coindre J, Bonichon F, Nguyen B, Terrier P, Collin F . Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997; 15(1):350-62. DOI: 10.1200/JCO.1997.15.1.350. View

16.

Tian W, Zhu Y, Wang Y, Teng F, Zhang H, Liu G . Visfatin, a potential biomarker and prognostic factor for endometrial cancer. Gynecol Oncol. 2013; 129(3):505-12. DOI: 10.1016/j.ygyno.2013.02.022. View

17.

Edris B, Fletcher J, West R, van de Rijn M, Beck A . Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma. Sarcoma. 2012; 2012:805614. PMC: 3420093. DOI: 10.1155/2012/805614. View

18.

Buldak R, Buldak L, Polaniak R, Kukla M, Birkner E, Kubina R . Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rep. 2012; 29(2):771-8. DOI: 10.3892/or.2012.2175. View

19.

Lee M, Won Y, Shin Y, Kim J, Chun J . Reciprocal activation of hypoxia-inducible factor (HIF)-2α and the zinc-ZIP8-MTF1 axis amplifies catabolic signaling in osteoarthritis. Osteoarthritis Cartilage. 2015; 24(1):134-45. DOI: 10.1016/j.joca.2015.07.016. View

20.

Folgueira M, Carraro D, Brentani H, Patrao D, Mantovani Barbosa E, Netto M . Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res. 2005; 11(20):7434-43. DOI: 10.1158/1078-0432.CCR-04-0548. View